Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
Corrigendum to: “Identification of Potential Molecular Targets of Doxorubicin for Application in Skin Cancer: A Network Pharmacology and Molecular Docking Perspective”